Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder?
暂无分享,去创建一个
Liam Smeeth | L. Smeeth | A. Hall | Sara L. Thomas | E. Somers | Andrew J Hall | Emily C Somers | Sara L Thomas
[1] A. Ghezzi,et al. Thyroid function and autoimmunity during interferon β-1b treatment : A multicenter prospective study , 2001 .
[2] References , 1971 .
[3] D. Alarcón-Segovia,et al. Shared autoimmunity: The time has come , 2004, Current rheumatology reports.
[4] D. Isenberg,et al. The mosaic of autoimmunity. , 1989, Immunology today.
[5] A. Silman,et al. Anti-tumour necrosis factor α therapy in rheumatoid arthritis: an update on safety , 2004 .
[6] N. Rose. Autoimmune diseases. , 1981, Scientific American.
[7] L. Calzà,et al. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease , 2005, Brain Research Reviews.
[8] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[9] S. Walsh,et al. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. , 2000, American journal of public health.
[10] A. Ghezzi,et al. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. , 2001, The Journal of clinical endocrinology and metabolism.
[11] A. Oliviero,et al. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-β therapy for multiple sclerosis , 1998 .
[12] P. Box. Interferon beta-1b treatment does not induce autoantibodies , 2005 .
[13] E L Korn,et al. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.
[14] C. Pozzilli,et al. Interferon beta-1b treatment does not induce autoantibodies , 2005, Neurology.
[15] L. Smeeth,et al. Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. , 2007, Arthritis and rheumatism.
[16] T. Evans,et al. Thyroid disease. , 2003, Primary care.
[17] R. Jonsson,et al. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. , 1995, Autoimmunity.
[18] A. Muñoz,et al. Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[19] J. Hollowell,et al. The General Practice Research Database: quality of morbidity data. , 1997, Population trends.
[20] P. Royston,et al. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .
[21] Y. Shoenfeld,et al. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity , 2007, Expert review of clinical immunology.
[22] A. Silman,et al. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. , 2004, Annals of the rheumatic diseases.
[23] N. Sicotte,et al. Onset of multiple sclerosis associated with anti-TNF therapy , 2001, Neurology.
[24] W. Bilker,et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database , 2005, Pharmacoepidemiology and drug safety.
[25] L. Smeeth,et al. Autoimmune Diseases Co-occurring Within Individuals and Within Families: A Systematic Review , 2006, Epidemiology.
[26] W. Robinson,et al. Demyelination and inhibition of tumor necrosis factor (TNF). , 2004, Clinical and experimental rheumatology.
[27] L. Murri,et al. Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[28] Norman E. Breslow,et al. Multiplicative Models and Cohort Analysis , 1983 .
[29] S J Gange,et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.
[30] Y. Shoenfeld. The kaleidoscope of autoimmunity. , 1993, Autoimmunity.
[31] A. Ghezzi,et al. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases? , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[32] G. Cooper,et al. The epidemiology of autoimmune diseases. , 2003, Autoimmunity reviews.
[33] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .
[34] L. Calzà,et al. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Fox,et al. Th17 cells in human disease , 2008, Immunological reviews.
[36] T. Walley,et al. The UK General Practice Research Database , 1997, The Lancet.
[37] A. Verier,et al. Multiple sclerosis, interferon beta and clinical thyroid dysfunction , 2003, Acta neurologica Scandinavica.
[38] J. Anaya,et al. The Nature and Nurture of Common Autoimmunity , 2007, Annals of the New York Academy of Sciences.